Sommer, C., Jacob, S., Bargmann, T., Shoaib, M., Alshaikhdeeb, B., Satagopam, V. P., . . . Sewald, K. (2024). Bridging therapy-induced phenotypes and genetic immune dysregulation to study interleukin-2-induced immunotoxicology. Clinical immunology (Orlando, Fla.), 266, 110288. https://doi.org/10.1016/j.clim.2024.110288
Chicago ZitierstilSommer, Charline, et al. "Bridging Therapy-induced Phenotypes and Genetic Immune Dysregulation to Study Interleukin-2-induced Immunotoxicology." Clinical Immunology (Orlando, Fla.) 266 (2024): 110288. https://dx.doi.org/10.1016/j.clim.2024.110288.
MLA ZitierstilSommer, Charline, et al. "Bridging Therapy-induced Phenotypes and Genetic Immune Dysregulation to Study Interleukin-2-induced Immunotoxicology." Clinical Immunology (Orlando, Fla.), vol. 266, 2024, p. 110288.